GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » Debt-to-Asset

PharmaTher Holdings (XCNQ:PHRM) Debt-to-Asset : 0.00 (As of Feb. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings Debt-to-Asset?

PharmaTher Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2024 was C$0.00 Mil. PharmaTher Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2024 was C$0.00 Mil. PharmaTher Holdings's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Feb. 2024 was C$2.91 Mil. PharmaTher Holdings's debt to asset for the quarter that ended in Feb. 2024 was 0.00.


PharmaTher Holdings Debt-to-Asset Historical Data

The historical data trend for PharmaTher Holdings's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Debt-to-Asset Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23
Debt-to-Asset
- - -

PharmaTher Holdings Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PharmaTher Holdings's Debt-to-Asset

For the Biotechnology subindustry, PharmaTher Holdings's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaTher Holdings's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaTher Holdings's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where PharmaTher Holdings's Debt-to-Asset falls into.



PharmaTher Holdings Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

PharmaTher Holdings's Debt-to-Asset for the fiscal year that ended in May. 2023 is calculated as

PharmaTher Holdings's Debt-to-Asset for the quarter that ended in Feb. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaTher Holdings  (XCNQ:PHRM) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


PharmaTher Holdings Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaTher Holdings (XCNQ:PHRM) Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.
Executives
Fabio Chianelli Director, Senior Officer

PharmaTher Holdings (XCNQ:PHRM) Headlines

No Headlines